secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clene Inc. (CLNN)
CIK:        0001822791
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0001437749-24-011545
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clene enters $7.3M subaward with Columbia University for NIH-funded ALS Expanded Access Program
--------------------------------------------------------------------------------

- Clene Nanomedicine signed subaward for up to $7.3M for initial phase of NIH grant supporting CNM-Au8 EAP in ALS.
- Total subaward potential under $45.1M NIH grant could reach $30.9M through August 2027.
- Funds reimburse expenses from Sept 25, 2023 to Aug 31, 2024; invoiced monthly or quarterly.
- Agreement protects Clene's background IP; no license granted to Columbia or US Government.
- Either party may terminate with 30 days' notice; termination required if NIH terminates grant.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822791/000143774924011545/0001437749-24-011545-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822791/000143774924011545/clnn20240409_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-011545

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer